You searched for T cells - Page 3 of 41

In Depth 13 Dec 2023

Revolutionizing glioblastoma treatment: how CAR-T cell therapy could be used as a cure

…the immunosuppressive environment of the tumor. As the CAR-T cells killed tumor cells expressing the target antigen, host T cells then encountered other antigens from those tumor cells, in turn…

December 13, 2023 - 8 minutesmins - By Willow Shah-Neville

lab-grown meat, stem cell technology, cultured meat, stem cells

Stem Cell-based Cultured Meat: No Longer Science Fiction

…of the first type of stem cells, totipotent cells, that possess the ability to be programmed into any cell type, including embryonic and placental cells. Second are the pluripotent cells,…

August 26, 2021 - 7 minutesmins - By Sudha Sundaram

Best in Biotech 11 Jan 2024

Ten NK cell therapy companies to look out for this year

…that intend to treat AML, multiple myeloma, pancreatic, ovarian, and triple negative breast cancer. Last year, the biotech was awarded a patent for CISH knockout (KO) in NK cells, which…

January 11, 2024 - 11 minutesmins - By Roohi Mariam Peter

Best in Biotech 24 Feb 2020

Meet 20 European Immuno-Oncology Companies that are Fighting Cancer

…ligands that it recognizes are also expressed by the tumor microenvironment, which comprises the blood vessels that support the tumor and the cells that make sure the tumor can evade…

February 24, 2020 - 12 minutesmins - By Larissa Warneck-Silvestrin

cellular reprogramming with Shift Bioscience

News and Trends 21 Oct 2024

Turning back time with cellular reprogramming: Shift raises $16 million in seed funding

…the most exciting areas in aging research. At the core of this technology is the concept of reverting mature cells to a pluripotent state to reset their biological age. The…

October 21, 2024 - 9 minutesmins - By Jules Adam

In Depth 30 Nov 2020

Can Anti-Aging Research Keep Us Healthy in the Long Run?

…senescent cells from harming the tissue around them instead of killing them. Another strategy — out-licensed to the Swiss company Rejuversen — is to stop senescent cells hiding from the…

November 30, 2020 - 10 minutesmins - By Jonathan Smith

In Depth 12 Jun 2024

Stem cell therapy: a potential cure for hearing loss?

…the future so that we can roll this out – should this be successful – not just the most wealthy countries, and not just the wealthiest people in those countries…

June 12, 2024 - 10 minutesmins - By Roohi Mariam Peter

circulating tumor cells, cancer, clinical trials

News and Trends 19 Sep 2022

Tokyo scientists reveal possible new direction for getting rid of cancer cells

…Cell competition is achieved by healthy normal cells that surround mutant cancer cells through various mechanisms that trigger cell removal. In addition, epithelial cells – the type of cell that…

September 19, 2022 - 4 minutesmins - By Liza Laws

cell therapy manufacturing reprogramming synbio

News and Trends 22 Nov 2021

Investors Flock to Startups Reprogramming Cell Therapies

…hard to replicate and translate to human studies. The use of stem cells can tackle these problems. Instead of trying to source scarce adult cells, researchers could simply turn plentiful…

November 22, 2021 - 7 minutesmins - By Jonathan Smith

In Depth 4 Oct 2023

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

…relapse. This led to the discovery that CAR-NK cells that express the gene interleukin-15 (IL-15) can provide a prolonged anti-tumor response. “Our data suggest that successful treatment using CAR-NK cells…

October 4, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 12 Feb 2025

Dendritic cell therapy: Diakonos, Northwest Biotherapeutics and Mendus push ahead with next-generation candidates

…cells help stimulate the patient’s T cells to identify and attack cancer cells expressing those antigens.” Hartenbach said that, in principle, dendritic cell therapy can target almost any type of…

February 12, 2025 - 10 minutesmins - By Willow Shah-Neville

In Depth 22 Feb 2024

TIL therapies: the impact on cancer research

…In fact, this class of drugs is the first cell therapy to target a solid tumor. Unlike CAR-T, where cells are retrieved from the blood, TIL therapy takes T cell…

February 22, 2024 - 10 minutesmins - By Roohi Mariam Peter

Resources

Categories

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: T cells

Revolutionizing glioblastoma treatment: how CAR-T cell therapy could be used as a cure

Stem Cell-based Cultured Meat: No Longer Science Fiction

Ten NK cell therapy companies to look out for this year

Meet 20 European Immuno-Oncology Companies that are Fighting Cancer

Turning back time with cellular reprogramming: Shift raises $16 million in seed funding

Can Anti-Aging Research Keep Us Healthy in the Long Run?

Stem cell therapy: a potential cure for hearing loss?

Tokyo scientists reveal possible new direction for getting rid of cancer cells

Investors Flock to Startups Reprogramming Cell Therapies

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

Dendritic cell therapy: Diakonos, Northwest Biotherapeutics and Mendus push ahead with next-generation candidates

TIL therapies: the impact on cancer research

Subscribe to our newsletter to get the latest biotech news!

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!